| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/15/2003 | CN1391486A Methods for treating therapy-resistant tumors |
| 01/15/2003 | CN1391481A 疫苗 Vaccine |
| 01/15/2003 | CN1391435A Method for stabilizing and controlling apomixis |
| 01/15/2003 | CN1390954A Information processing system by using nucleotide sequence data concerned |
| 01/15/2003 | CN1390943A Refractor 6-phosphoglucose isomerase gene and its polypeptide coded by it and preparing process |
| 01/15/2003 | CN1390942A Glucanase gene and lichenbacillus |
| 01/15/2003 | CN1390941A Refractory cytidylic acid kinase gene and its polypeptide coded by it and preparing process |
| 01/15/2003 | CN1390940A 4-coumaric acid: CoA ligase gene and its clone |
| 01/15/2003 | CN1390939A Rice plant with high accumulating capability to proline and production thereof |
| 01/15/2003 | CN1390938A hMCP-DAF fusion gene and its polypeptide coded by it and configuring process |
| 01/15/2003 | CN1390937A Spider silk protein gene designed and synthesized by plant preference codon and its application |
| 01/15/2003 | CN1390936A Human atrial natriuretic peptide gene, its strong mutant and its application in treating relative diseases |
| 01/15/2003 | CN1390935A Human hematolysis associated membrane protein and its coding sequence, preparing process and usage |
| 01/15/2003 | CN1390934A Particular sequence on chromogenom of class-2 intron target integrated eukaryocyte |
| 01/15/2003 | CN1390852A Human auricular fibrillation pathogene and coding protein and its usage |
| 01/15/2003 | CN1390851A Bombesin of Bombina maxima and its preparing process and genes |
| 01/15/2003 | CN1390850A Neurotrophic factor of Bombina maxima and its preparing process and genes |
| 01/15/2003 | CN1390849A Neurotrophic peptide of Bombina maxima and its preparing process and genes |
| 01/15/2003 | CN1390848A Bradykinin of Bombina maxima and its preparing process and genes |
| 01/15/2003 | CN1390847A Salmon's calcitonin gene synthesized by plant preference codon and its application |
| 01/15/2003 | CN1098932C Method of synthesizing fluorescently labeled protein |
| 01/15/2003 | CN1098931C Application of glucose oxidase gene to breeding disease-resistant transfer-gene |
| 01/15/2003 | CN1098930C GRB3-3 gene, variants and uses thereof |
| 01/14/2003 | US6507788 Analyzing chemical intermediates having amidated end groups using computers to screen for codons from nucleotide sequences, then determining codes for polypeptides; genetic translation |
| 01/14/2003 | US6506963 Hybrid winter oilseed rape and methods for producing same |
| 01/14/2003 | US6506962 Disease resistance |
| 01/14/2003 | US6506895 Photoactivatable nucleic acids |
| 01/14/2003 | US6506893 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 01/14/2003 | US6506892 Interleukin X (IL-X) controls cellular proliferation; anticarcinogenic agents |
| 01/14/2003 | US6506891 Cell surface molecule-induced macrophage activation |
| 01/14/2003 | US6506890 Adding polycation to prevent aggregation; automatic |
| 01/14/2003 | US6506888 Viricides, antitumor and anticarcinogenic agents |
| 01/14/2003 | US6506887 Conditional-selex |
| 01/14/2003 | US6506883 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 01/14/2003 | US6506881 Specific for human milk fat globule; complementarity determining region derived from variable domains of mouse monoclonal antibody |
| 01/14/2003 | US6506879 Endotoxin-free; genetically expressed in bacteria; atherosclerosis and cardiovascular disorder treatment |
| 01/14/2003 | US6506878 HMTF81 human 7-transmembrane receptor |
| 01/14/2003 | US6506875 Diagnostic epitopes |
| 01/14/2003 | US6506874 Hypoglycemic agents; obesity, nervous system, cardiovascular, and kidney disorder treatment |
| 01/14/2003 | US6506735 Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences |
| 01/14/2003 | US6506604 Retroviral packaging system |
| 01/14/2003 | US6506603 DNA reassembly after random fragmentation; mutagenesis cycles; denaturing, incubation, genetic engineering, screening |
| 01/14/2003 | US6506602 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 01/14/2003 | US6506600 Secreting products from skin by adeno-associated virus (AAV) gene transfer |
| 01/14/2003 | US6506598 Gene expression of tissue plasminogen activator in butyrate salt |
| 01/14/2003 | US6506596 Generating apoptotic bodies of somatic donor cells, incubating to allow for integration of DNA of the bodies into engulfing recipient cells |
| 01/14/2003 | US6506595 DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs |
| 01/14/2003 | US6506594 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| 01/14/2003 | US6506593 Production of thermostable xyalnases useful for modifying plant biomass and for enzyme-aided bleaching of wood pulp |
| 01/14/2003 | US6506592 Hyperthermophilic alpha-glucosidase gene and its use |
| 01/14/2003 | US6506590 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 01/14/2003 | US6506589 Useful mutations of bacterial alkaline protease |
| 01/14/2003 | US6506587 Nucleotide sequences coding enzymatic polypeptide; for use as an antitumor a gents |
| 01/14/2003 | US6506586 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506585 Polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506583 Culturing in glycerol, fructose, sorbose, mannitol, sorbitol, inositol, or glucose; fermentation; isolating nontoxic lipopolysaccharide produced by mutant |
| 01/14/2003 | US6506582 Extended by aspartic acid at 5' end and shortened at 3' end by one to eight amino acids; nonimmunogenic; binds CD4 lymphocytes |
| 01/14/2003 | US6506581 Nucleotide sequence of the Haemophilus influenzae Rd genome, fragments thereof, and uses thereof |
| 01/14/2003 | US6506580 Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening |
| 01/14/2003 | US6506579 Increasing production of proteins in gram-positive microorganisms using SecG |
| 01/14/2003 | US6506574 Drug screening, liver replenishment; culturing with cellular differentiation agent |
| 01/14/2003 | US6506570 Method of sorting birds in ovo |
| 01/14/2003 | US6506566 Screening enzymatic polypeptides for use in detergents; obtain microorganism expressing polypeptides, incubate with detergent, expose to binding protein, separate bound complex, isolate and propagate genome coding enzymatic variant |
| 01/14/2003 | US6506565 Transgenic plant; genetic engineering |
| 01/14/2003 | US6506561 Method of obtaining a library of tags capable of defining a specific state of a biological sample |
| 01/14/2003 | US6506560 Cloned DNA polymerases from Thermotoga and mutants thereof |
| 01/14/2003 | US6506559 Molecular hybridization of complementary strands |
| 01/14/2003 | US6506557 Methods and compositions for identifying a protease |
| 01/14/2003 | US6506556 Applying a recombinant insect virus containing a vector which is highly virulent to the locus, foliage or stem of a transgenic crop; nonpolluting |
| 01/14/2003 | US6506415 Method of inducing resistance to tumor growth |
| 01/14/2003 | US6506383 Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies |
| 01/14/2003 | US6506379 Intramuscular delivery of recombinant AAV |
| 01/14/2003 | US6506365 Fibrin/fibrinogen binding conjugate |
| 01/14/2003 | US6506343 Supports filter media at each well, without creating prefer-ential flow; provides separate collection of filtrate from each well |
| 01/14/2003 | CA2194444C Immunomodulators |
| 01/14/2003 | CA2116859C Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
| 01/14/2003 | CA2102595C Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 01/14/2003 | CA2027355C Yeast promoter |
| 01/13/2003 | CA2393376A1 Assay methods |
| 01/10/2003 | CA2390522A1 Enzyme/tag binding and detection system |
| 01/09/2003 | WO2003003018A2 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 01/09/2003 | WO2003003015A2 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof |
| 01/09/2003 | WO2003003014A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 01/09/2003 | WO2003003013A1 Non-nuclear effects of thyroid hormone |
| 01/09/2003 | WO2003003010A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson’s disease |
| 01/09/2003 | WO2003003006A2 New potent, selective and non toxic c-kit inhibitors |
| 01/09/2003 | WO2003002765A2 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/09/2003 | WO2003002763A1 Use of a biochip for the diagnosis of sepsis or sepsis related syndrome |
| 01/09/2003 | WO2003002761A1 Method of multimerization and site-directed mutagenesis |
| 01/09/2003 | WO2003002758A1 Nucleic acid ligands to complex targets |
| 01/09/2003 | WO2003002756A1 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 01/09/2003 | WO2003002753A2 Diagnostic assays for parvovirus b19 |
| 01/09/2003 | WO2003002751A2 Alteration of oil traits in plants |
| 01/09/2003 | WO2003002750A2 High throughput assay system |
| 01/09/2003 | WO2003002749A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 01/09/2003 | WO2003002746A2 Perv screening method and use thereof |
| 01/09/2003 | WO2003002745A2 The cage gene of actinobacillus actinomycetemcomitans, the protein it encodes and uses thereof |
| 01/09/2003 | WO2003002744A1 Human cervical cancer 2 proto-oncogene and protein encoded therein |
| 01/09/2003 | WO2003002743A1 Human cervical cancer 7 proto-oncogene and protein encoded therein |
| 01/09/2003 | WO2003002742A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |